Literature DB >> 11175849

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics.

S A Stacker1, C Caesar, M E Baldwin, G E Thornton, R A Williams, R Prevo, D G Jackson, S Nishikawa, H Kubo, M G Achen.   

Abstract

Metastasis to local lymph nodes via the lymphatic vessels is a common step in the spread of solid tumors. To investigate the molecular mechanisms underlying the spread of cancer by the lymphatics, we examined the ability of vascular endothelial growth factor (VEGF)-D, a ligand for the lymphatic growth factor receptor VEGFR-3/Flt-4, to induce formation of lymphatics in a mouse tumor model. Staining with markers specific for lymphatic endothelium demonstrated that VEGF-D induced the formation of lymphatics within tumors. Moreover, expression of VEGF-D in tumor cells led to spread of the tumor to lymph nodes, whereas expression of VEGF, an angiogenic growth factor which activates VEGFR-2 but not VEGFR-3, did not. VEGF-D also promoted tumor angiogenesis and growth. Lymphatic spread induced by VEGF-D could be blocked with an antibody specific for VEGF-D. This study demonstrates that lymphatics can be established in solid tumors and implicates VEGF family members in determining the route of metastatic spread.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11175849     DOI: 10.1038/84635

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  312 in total

1.  An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype.

Authors:  Jeffrey T Wigle; Natasha Harvey; Michael Detmar; Irina Lagutina; Gerard Grosveld; Michael D Gunn; David G Jackson; Guillermo Oliver
Journal:  EMBO J       Date:  2002-04-02       Impact factor: 11.598

2.  B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis.

Authors:  Alanna Ruddell; Pau Mezquita; Kimberly A Brandvold; Andrew Farr; Brian M Iritani
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 3.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

4.  In vivo imaging of lymphatic vessels in development, wound healing, inflammation, and tumor metastasis.

Authors:  Inés Martínez-Corral; David Olmeda; Rodrigo Diéguez-Hurtado; Tuomas Tammela; Kari Alitalo; Sagrario Ortega
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

5.  Slit-Robo signaling mediates lymphangiogenesis and promotes tumor lymphatic metastasis.

Authors:  Xiao-Mei Yang; Hai-Xiong Han; Fei Sui; Yu-Min Dai; Ming Chen; Jian-Guo Geng
Journal:  Biochem Biophys Res Commun       Date:  2010-05-08       Impact factor: 3.575

6.  Lymphatic injury and regeneration in cardiac allografts.

Authors:  Thing Rinda Soong; Arvind P Pathak; Hiroshi Asano; Karen Fox-Talbot; William M Baldwin
Journal:  Transplantation       Date:  2010-03-15       Impact factor: 4.939

7.  Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation.

Authors:  Emma J Gordon; Sujata Rao; Jeffrey W Pollard; Stephen L Nutt; Richard A Lang; Natasha L Harvey
Journal:  Development       Date:  2010-11       Impact factor: 6.868

8.  Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors.

Authors:  Vivien Schacht; Soheil S Dadras; Louise A Johnson; David G Jackson; Young-Kwon Hong; Michael Detmar
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

9.  Vascular endothelial growth factor D is dispensable for development of the lymphatic system.

Authors:  Megan E Baldwin; Michael M Halford; Sally Roufail; Richard A Williams; Margaret L Hibbs; Dianne Grail; Hajime Kubo; Steven A Stacker; Marc G Achen
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

10.  Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis.

Authors:  Natalie O Karpinich; Daniel O Kechele; Scott T Espenschied; Helen H Willcockson; Yuri Fedoriw; Kathleen M Caron
Journal:  FASEB J       Date:  2012-10-25       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.